Breitfeld Philip P. 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Mar 25, 2021
Insider Transaction Report
Form 4
Breitfeld Philip P.
Director
Transactions
- Exercise/Conversion
Option to purchase Common Stock
2021-03-23−4,167→ 0 totalExercise: $3.65Exp: 2021-04-11→ Common Stock (4,167 underlying) - Exercise/Conversion
Common Stock
2021-03-23$3.65/sh+4,167$15,210→ 4,167 total - Tax Payment
Common Stock
2021-03-23$11.35/sh−1,340$15,209→ 2,827 total
Footnotes (2)
- [F1]Represents a "net exercise" of outstanding stock options. These shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on March 23, 2021.
- [F2]The options vest and are exercisable over a four month period, with vesting to occur on May 1, 2016 and August 1, 2016, respectively.